var singsData = [{"date":new Date(2012,1,8),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,1,8),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,1,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains CVS to Buy. Target Price is $51; previously $45.","showOnAxis":false},{"date":new Date(2012,1,9),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Goldman Sachs maintains CVS to Buy. Target Price is $48; previously $46.","showOnAxis":false},{"date":new Date(2012,1,9),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains CVS to Buy. Target Price is $49; previously $48.","showOnAxis":false},{"date":new Date(2012,10,26),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,10,26),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2012,10,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,10,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,10,6),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, CVS reports 2012 Q3's earning $0.85 per share and revenue $30230MM. This beats analyst's estimated EPS $0.84, beats estimated revenue $30090MM.","showOnAxis":false},{"date":new Date(2012,10,6),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"ISI Group maintains CVS to Overweight. Target Price is $53.5; previously $54.","showOnAxis":false},{"date":new Date(2012,10,6),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains CVS to Buy. Target Price is $54; previously $50.","showOnAxis":false},{"date":new Date(2012,10,7),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"BMO Capital maintains CVS to Outperform. Target Price is $55; previously $53.","showOnAxis":false},{"date":new Date(2012,10,7),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains CVS to Overweight. Target Price is $54; previously $50.","showOnAxis":false},{"date":new Date(2012,10,7),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains CVS to Buy. Target Price is $54; previously $50.","showOnAxis":false},{"date":new Date(2012,11,10),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,11,10),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2012,11,13),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,11,13),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,11,13),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"ISI Group maintains CVS to Overweight. Target Price is $57; previously $53.5.","showOnAxis":false},{"date":new Date(2012,11,14),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Macquarie upgrades CVS to Outperform from Neutral.","showOnAxis":false},{"date":new Date(2012,11,14),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Macquarie upgrades CVS to Outperform from Neutral. Target Price is $55; previously $50.","showOnAxis":false},{"date":new Date(2012,11,14),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Cantor Fitzgerald maintains CVS to Buy. Target Price is $57; previously $55.","showOnAxis":false},{"date":new Date(2012,11,14),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse maintains CVS to Outperform. Target Price is $55; previously $50.","showOnAxis":false},{"date":new Date(2012,11,14),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains CVS to Overweight. Target Price is $59; previously $57.","showOnAxis":false},{"date":new Date(2012,11,14),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Morgan Stanley maintains CVS to Overweight. Target Price is $55; previously $53.","showOnAxis":false},{"date":new Date(2012,11,14),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains CVS to Buy. Target Price is $55; previously $53.","showOnAxis":false},{"date":new Date(2012,11,20),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains CVS to Buy. Target Price is $58; previously $54.","showOnAxis":false},{"date":new Date(2012,11,24),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,11,24),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2012,2,1),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2012,2,13),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"BMO Capital downgrades CVS to Market Perform from Outperform. Target Price is $47.","showOnAxis":false},{"date":new Date(2012,2,29),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2012,2,29),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,2,7),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Morgan Stanley maintains CVS to Overweight. Target Price is $52; previously $48.","showOnAxis":false},{"date":new Date(2012,3,19),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.163","showOnAxis":true},{"date":new Date(2012,4,1),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CVS reports 2012 Q1's earning $0.59 per share and revenue $30798MM..","showOnAxis":false},{"date":new Date(2012,4,10),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2012,4,10),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,4,10),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2012,4,2),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,4,2),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,4,3),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains CVS to Buy. Target Price is $52; previously $50.","showOnAxis":false},{"date":new Date(2012,4,3),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains CVS to Buy. Target Price is $53; previously $49.","showOnAxis":false},{"date":new Date(2012,6,12),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"ISI Group initiates coverage on CVS to Overweight. Target Price is $53.5.","showOnAxis":false},{"date":new Date(2012,6,17),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JMP Securities assumes CVS to Market Outperform.","showOnAxis":false},{"date":new Date(2012,6,19),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.163","showOnAxis":true},{"date":new Date(2012,7,14),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Cantor Fitzgerald initiates coverage on CVS to Buy. Target Price is $55.","showOnAxis":false},{"date":new Date(2012,7,7),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,7,7),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,7,7),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CVS reports 2012 Q2's earning $0.81 per share and revenue $30700MM. This beats analyst's estimated EPS $0.79, misses estimated revenue $30980MM.","showOnAxis":false},{"date":new Date(2012,7,7),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"ISI Group maintains CVS to Overweight. Target Price is $51.5; previously $52.","showOnAxis":false},{"date":new Date(2012,7,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains CVS to Buy. Target Price is $60; previously $52.","showOnAxis":false},{"date":new Date(2012,7,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains CVS to Overweight. Target Price is $52; previously $51.","showOnAxis":false},{"date":new Date(2012,7,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains CVS to Buy. Target Price is $52; previously $50.","showOnAxis":false},{"date":new Date(2012,8,19),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2012,8,19),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,8,19),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2012,9,18),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.163","showOnAxis":true},{"date":new Date(2013,0,22),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.225","showOnAxis":true},{"date":new Date(2013,1,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,1,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,1,6),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CVS reports 2012 Q4's earning $1.14 per share and revenue $31390MM. This beats analyst's estimated EPS $1.1, beats estimated revenue $31130MM.","showOnAxis":false},{"date":new Date(2013,10,20),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank initiates coverage on CVS to Hold. Target Price is $71.","showOnAxis":false},{"date":new Date(2013,10,25),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,10,26),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2013,10,26),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,10,29),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Morgan Stanley maintains CVS to Overweight. Target Price is $65.","showOnAxis":false},{"date":new Date(2013,10,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,10,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,10,5),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CVS reports 2013 Q3's earning $1.09 per share and revenue $31970MM. This beats analyst's estimated EPS $1.02, beats estimated revenue $31530MM.","showOnAxis":false},{"date":new Date(2013,10,6),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"BMO Capital maintains CVS to Outperform. Target Price is $70; previously $66.","showOnAxis":false},{"date":new Date(2013,11,10),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2013,11,11),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse maintains CVS to Outperform. Target Price is $75; previously $70.","showOnAxis":false},{"date":new Date(2013,11,18),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,11,18),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,11,19),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Morgan Stanley maintains CVS to Overweight. Target Price is $76; previously $65.","showOnAxis":false},{"date":new Date(2013,11,2),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,11,2),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2013,11,20),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains CVS to Hold. Target Price is $76; previously $71.","showOnAxis":false},{"date":new Date(2013,2,12),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Goldman Sachs downgrades CVS to Neutral from Buy. Target Price is $57.","showOnAxis":false},{"date":new Date(2013,2,29),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,3,14),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Goldman Sachs maintains CVS to Neutral. Target Price is $60; previously $57.","showOnAxis":false},{"date":new Date(2013,3,19),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.225","showOnAxis":true},{"date":new Date(2013,3,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains CVS to Buy. Target Price is $70; previously $60.","showOnAxis":false},{"date":new Date(2013,3,26),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,3,26),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,4,1),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,4,1),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CVS reports 2013 Q1's earning $0.83 per share and revenue $30760MM. This beats analyst's estimated EPS $0.79, beats estimated revenue $30360MM.","showOnAxis":false},{"date":new Date(2013,4,13),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2013,4,13),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,4,13),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,4,13),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2013,4,14),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2013,4,31),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Wells Fargo initiates coverage on CVS to Outperform.","showOnAxis":false},{"date":new Date(2013,6,10),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,6,18),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.225","showOnAxis":true},{"date":new Date(2013,7,2),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,7,2),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2013,7,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,7,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,7,6),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CVS reports 2013 Q2's earning $0.97 per share and revenue $31248MM. This beats analyst's estimated EPS $0.96, beats estimated revenue $31140MM.","showOnAxis":false},{"date":new Date(2013,7,7),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Cantor Fitzgerald downgrades CVS to Hold from Buy. Target Price is $62; previously $65.","showOnAxis":false},{"date":new Date(2013,8,13),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Cowen & Co. initiates coverage on CVS to Market Perform. Target Price is $66.","showOnAxis":false},{"date":new Date(2013,8,25),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,9,17),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.225","showOnAxis":true},{"date":new Date(2013,9,7),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies initiates coverage on CVS to Buy. Target Price is $71.","showOnAxis":false},{"date":new Date(2014,0,21),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.275","showOnAxis":true},{"date":new Date(2014,0,22),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"ISI Group upgrades CVS to Strong Buy from Buy. Target Price is $78.5.","showOnAxis":false},{"date":new Date(2014,0,9),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2014,0,9),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,0,9),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Leerink Swann initiates coverage on CVS to Outperform. Target Price is $85.","showOnAxis":false},{"date":new Date(2014,1,11),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,1,11),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,1,11),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CVS reports 2013 Q4's earning $1.12 per share and revenue $32800MM. This beats analyst's estimated EPS $1.11, beats estimated revenue $32670MM.","showOnAxis":false},{"date":new Date(2014,1,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2014,10,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,10,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,10,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains CVS to Hold. Target Price is $90; previously $84.","showOnAxis":false},{"date":new Date(2014,10,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"FBR Capital maintains CVS to Outperform. Target Price is $92; previously $90.","showOnAxis":false},{"date":new Date(2014,11,10),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup initiates coverage on CVS to Neutral. Target Price is $99.","showOnAxis":false},{"date":new Date(2014,11,16),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,11,16),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,11,17),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains CVS to Overweight. Target Price is $107; previously $98.","showOnAxis":false},{"date":new Date(2014,11,17),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse maintains CVS to Outperform. Target Price is $101; previously $95.","showOnAxis":false},{"date":new Date(2014,11,17),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains CVS to Overweight. Target Price is $108; previously $92.","showOnAxis":false},{"date":new Date(2014,11,19),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"SunTrust Robinson Humphrey upgrades CVS to Buy. Target Price is $110.","showOnAxis":false},{"date":new Date(2014,3,17),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.275","showOnAxis":true},{"date":new Date(2014,4,2),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,4,2),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,4,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains CVS to Overweight. Target Price is $85; previously $74.","showOnAxis":false},{"date":new Date(2014,4,8),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2014,6,17),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.275","showOnAxis":true},{"date":new Date(2014,7,21),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,7,21),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2014,7,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,7,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,7,6),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains CVS to Overweight. Target Price is $87; previously $85.","showOnAxis":false},{"date":new Date(2014,7,6),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains CVS to Overweight. Target Price is $91; previously $82.","showOnAxis":false},{"date":new Date(2014,7,7),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,7,7),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2014,8,15),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Cowen & Co. upgrades CVS to Outperform from Market Perform. Target Price is $92; previously $85.","showOnAxis":false},{"date":new Date(2014,8,3),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2014,8,3),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,8,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,8,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2014,9,21),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.275","showOnAxis":true},{"date":new Date(2015,0,2),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Bank of America maintains CVS to Buy. Target Price is $104; previously $94.","showOnAxis":false},{"date":new Date(2015,0,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,0,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,0,20),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.35","showOnAxis":true},{"date":new Date(2015,0,21),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Goldman Sachs upgrades CVS to Buy from Neutral. Target Price is $113; previously $95.","showOnAxis":false},{"date":new Date(2015,0,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains CVS to Overweight. Target Price is $116; previously $108.","showOnAxis":false},{"date":new Date(2015,1,10),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,1,10),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,1,13),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains CVS to Neutral. Target Price is $110; previously $102.","showOnAxis":false},{"date":new Date(2015,1,13),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains CVS to Hold. Target Price is $109; previously $100.","showOnAxis":false},{"date":new Date(2015,10,2),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains CVS to Overweight. Target Price is $123; previously $128.","showOnAxis":false},{"date":new Date(2015,10,2),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Oppenheimer maintains CVS to Outperform. Target Price is $115; previously $122.","showOnAxis":false},{"date":new Date(2015,11,16),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,11,16),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,11,17),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Goldman Sachs downgrades CVS to Neutral from Buy.","showOnAxis":false},{"date":new Date(2015,11,18),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays assumes CVS to Overweight. Target Price is $110.","showOnAxis":false},{"date":new Date(2015,2,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,3,22),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.35","showOnAxis":true},{"date":new Date(2015,3,27),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains CVS to Buy. Target Price is $120; previously $115.","showOnAxis":false},{"date":new Date(2015,4,1),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,4,1),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,4,12),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2015,4,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2015,4,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,4,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,4,7),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2015,5,10),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Cowen & Co. maintains CVS to Outperform. Target Price is $115; previously $108.","showOnAxis":false},{"date":new Date(2015,5,12),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2015,5,18),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Oppenheimer initiates coverage on CVS to Outperform. Target Price is $119.","showOnAxis":false},{"date":new Date(2015,5,9),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Macquarie initiates coverage on CVS to Outperform. Target Price is $115.","showOnAxis":false},{"date":new Date(2015,6,13),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2015,6,13),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,6,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,6,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,6,21),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.35","showOnAxis":true},{"date":new Date(2015,7,18),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Completion of Acquisition or Disposition of Assets\r\n","showOnAxis":true},{"date":new Date(2015,7,18),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,7,28),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Oppenheimer maintains CVS to Outperform. Target Price is $122; previously $119.","showOnAxis":false},{"date":new Date(2015,7,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,7,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,8,22),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,8,22),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,9,20),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.35","showOnAxis":true},{"date":new Date(2015,9,30),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,9,30),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,9,30),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CVS reports 2015 Q3's earning $1.29 per share and revenue $38644MM. This meets analyst's estimated EPS $1.29, beats estimated revenue $37890MM.","showOnAxis":false},{"date":new Date(2015,9,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,9,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2016,0,20),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.425","showOnAxis":true},{"date":new Date(2016,0,21),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2016,0,21),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,0,22),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Baird initiates coverage on CVS to Outperform. Target Price is $108.","showOnAxis":false},{"date":new Date(2016,1,3),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Atlantic Equities initiates coverage on CVS to Overweight.","showOnAxis":false},{"date":new Date(2016,1,9),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,1,9),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,10,8),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,10,8),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,10,8),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CVS reports 2016 Q3's earning $1.64 per share and revenue $44615MM. This beats analyst's estimated EPS $1.57, misses estimated revenue $45290MM.","showOnAxis":false},{"date":new Date(2016,11,12),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies assumes CVS to Hold from Buy. Target Price is $82; previously $122.","showOnAxis":false},{"date":new Date(2016,2,10),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays assumes CVS to Overweight. Target Price is $115; previously $110.","showOnAxis":false},{"date":new Date(2016,2,15),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse assumes CVS to Outperform. Target Price is $115.","showOnAxis":false},{"date":new Date(2016,3,20),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.425","showOnAxis":true},{"date":new Date(2016,4,12),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains CVS to Buy. Target Price is $122; previously $110.","showOnAxis":false},{"date":new Date(2016,4,16),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,4,16),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2016,4,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2016,4,25),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,4,25),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2016,4,3),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,4,3),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,4,31),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,4,31),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2016,4,9),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains CVS to Neutral. Target Price is $115; previously $105.","showOnAxis":false},{"date":new Date(2016,5,14),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,5,14),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2016,5,2),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2016,5,20),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Morgan Stanley downgrades CVS to Equal-Weight. Target Price is $104; previously $111.","showOnAxis":false},{"date":new Date(2016,6,19),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.425","showOnAxis":true},{"date":new Date(2016,7,2),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,7,2),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,7,2),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CVS reports 2016 Q2's earning $1.32 per share and revenue $43725MM. This beats analyst's estimated EPS $1.3, misses estimated revenue $44280MM.","showOnAxis":false},{"date":new Date(2016,7,3),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains CVS to Hold. Target Price is $108; previously $99.","showOnAxis":false},{"date":new Date(2016,7,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains CVS to Neutral. Target Price is $108; previously $115.","showOnAxis":false},{"date":new Date(2016,9,20),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.425","showOnAxis":true},{"date":new Date(2016,9,3),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Baird maintains CVS to Outperform. Target Price is $104; previously $114.","showOnAxis":false},{"date":new Date(2016,9,3),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Bank of America maintains CVS to Buy. Target Price is $107; previously $110.","showOnAxis":false},{"date":new Date(2016,9,6),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS initiates coverage on CVS to Buy.","showOnAxis":false},{"date":new Date(2017,0,20),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.5","showOnAxis":true},{"date":new Date(2017,1,2),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Baird downgrades CVS to Neutral from Outperform.","showOnAxis":false}];